通过孟德尔随机化评估血咖啡因与癌症风险之间的关联的遗传估计
Hao Wang1, Keru Ma1, Ming Shan2
1Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
European journal of nutrition
|April 5, 2025
概括
高血咖啡因水平与增加肺癌风险有遗传联系. 这项门德尔的随机化研究表明了潜在的因果关系,需要对咖啡因进行进一步调查.
科学领域:
- 遗传学 遗传学 是一个
- 流行病学 流行病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 观察性研究没有确定血咖啡因与癌症风险之间的因果关系.
- 门德尔随机化 (MR) 提供了一种方法来研究基因对癌症风险的影响.
- 这项研究使用MR来探索血咖啡因水平与癌症发病率之间的关系.
研究的目的:
- 研究基因决定的血咖啡因水平对癌症风险的潜在因果作用.
- 为了利用与血咖啡因相关的遗传变异作为工具变量.
- 评估基因预测血咖啡因与整体和特定癌症类型之间的关联.
主要方法:
- 利用了来自9,876名欧洲祖先个体的血咖啡因全基因组关联研究 (GWAS) 数据.
- 选择了8个单核酸多态 (SNPs) 作为血咖啡因水平的仪器变量.
- 采用逆方差加权 (IVW) 和沃尔德比率方法来分析来自芬兰生物库和国家健康记录的癌症结局GWAS数据.
主要成果:
- 基因预测较高的血咖啡因水平与增加的肺癌风险显著相关 (OR=1.54,P<0.001).
- 发现了与肺状细胞癌 (OR=1.60,P=0.037) 和非小细胞肺癌 (OR=1.51,P=0.003) 的特定关联.
- 在FDR调整后,结果很强.
结论:
- 正如遗传学预测的那样,长期高血咖啡因水平与患肺癌的风险更高有关.
- 这些发现表明存在潜在的因果关系,需要进一步研究.
- 关于咖啡因摄入,补充或停止用于癌症预防或治疗的临床影响需要进一步研究.
相关概念视频
02:59Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K